Pharmasave Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Pharmasave
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vibha Bhagirath, Sanjay Tapadia, and Rameshchandra Katragadda serve as directors at the Company.
- CIN/LLPIN
U74999TG2021PTC154426
- Company No.
154426
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmasave?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Tapadia  | Director | 28-Aug-2021 | Current |
| Vibha Bhagirath | Director | 28-Aug-2021 | Current |
| Rameshchandra Katragadda | Director | 28-Aug-2021 | Current |
Financial Performance of Pharmasave.
Pharmasave Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmasave?
In 2022, Pharmasave had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zoi Hospitals Private LimitedActive 13 years 3 monthsVibha Bhagirath, Sanjay Tapadia and 1 more are mutual person
Shivam Medisoft Services Private LimitedActive 13 years 7 monthsRameshchandra Katragadda is a mutual person
Zoi Health Private LimitedActive 7 years 7 monthsSanjay Tapadia and Rameshchandra Katragadda are mutual person
Ikshana Facilities Private LimitedActive 1 year 11 monthsSanjay Tapadia and Rameshchandra Katragadda are mutual person
- Zoi Orthopedic Institute Private LimitedActive 10 months 4 days
Sanjay Tapadia and Rameshchandra Katragadda are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmasave?
Pharmasave has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmasave, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmasave's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
